Response to Afatinib in a Patient with NSCLC Harboring Novel EGFR Exon 20 Insertion Mutations.
Ling LinXiao Mai WuShuangquan YanYefei ZhuZhengqing YanDongqing LvHongfei GePublished in: OncoTargets and therapy (2020)
This is the first published case report of EGFR N771delinsKG lung adenocarcinoma, which highlighted the heterogeneity of clinical response to TKIs for EGFR ex20ins-mutant NSCLC. Such results need to be further investigated in prospective studies.